Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention of SARS-CoV2; Pharmaceutical preparations for the prevention of hypertension, inflammation, fibrosis, cardiovascular, and kidney diseases; Pharmaceutical preparations for the treatment and prevention of SARS-CoV2; Pharmaceutical preparations for the treatment and prevention of hypertension, inflammation, fibrosis, cardiovascular, and kidney diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of SARS-CoV2; Pharmaceutical preparations for the treatment of hypertension, inflammation, fibrosis, cardiovascular, and kidney diseases; Pharmaceutical preparations for modulating ACE-2 receptors; Pharmaceutical products for treating respiratory diseases; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with ACE-2 inhibitors; Therapeutic pharmaceutical for the treatment of SARS-CoV2; Therapeutic pharmaceutical for the treatment of hypertension, inflammation, fibrosis, cardiovascular, and kidney diseases
Pharmaceuticals